Events | Upcoming Events
August 14th -15th, 2008 | Toronto, Canada

Managing Aseptic Processing Operations

For Pharmaceutical, Biopharmaceutical, and Biotech Industries

A Two Day COMPREHENSIVE & INTERACTIVE COURSE with Workshops and Discussions On:

  • GMP Guidelines and Expectations for Aseptic Processing
  • FDA Aseptic Processing Guidance; EU Annex 1 Revisions
  • Avoiding Common Problems in Sterile Filtration
  • How to Establish a Sterility Sampling Program
  • Setting Media Fill Requirements and Acceptance Criteria
  • Conducting a Media Fill Failure Investigation
  • Proper Incubation Methods and Issues
  • Strategies for Investigating Sterility Failures
  • Conducting Laboratory and Manufacturing OOS Investigations
  • Using Corrective and Preventative Action Plan (CAPA)
  • Cleanroom Design Criteria and Maintenance Programs
  • Personnel Training and Operator Qualification
  • Equipment and Process Qualification Requirements
  • Designing the Cleaning Process in an Aseptic Environment
  • Choosing Test Criteria for Markers supporting Cleaning Validation
  • Document Control for the Cleaning Process
  • Effectively Auditing Aseptic Processes and Facilities
  • Vendor Selection and Documentation Requirements

Distinguished Panel of Speakers:

Dr. Carolyn Broughton
Scientist, Quality Control
Genentech

Carolyn Broughton, PhD, is currently a Scientist in Quality Control at Genentech, Inc. She has more than twenty years of experience managing microbiology laboratories in the biotechnology, pharmaceutical and cosmetics industries. She has authored articles for professional journals, presented at professional meetings, and provided training at laboratory courses. She received her PhD in Microbiology from North Carolina State University.

Joseph Brower
Vice President
MKCS

Joseph Brower is Vice President of MKCS, Inc., a full service systems integration firm providing automation and control solutions to the pharmaceutical, industrial, and manufacturing industries. Prior to joining MKCS, he served as Plant Manager for a start-up sterile manufacturing plant in Raleigh, NC. Brower has held positions in Operations, R&D, and Technical Services for 5 sterile product manufacturers over 20 years. Mr. Brower has been involved in the procurement, testing, installation, and operation of sterile processing equipment including, vial washers, tunnels, ovens, fillers for multiple dosage forms, automated lyophilization and loading equipment, as well as equipment for support areas and utilities. Mr. Brower has a Bachelor’s Degree in biology from Kent State University in Ohio, and an MBA from Michigan State University. Brower lives Raleigh, NC.

Mr. David Vincent
CEO
Validation Technologies, Inc.

Mr. Vincent is the Chief Executive Office (CEO) of Validation Technologies Inc. CA - USA. He has over 23 years experience in the health care industry with 17 years in field of validation. Mr. Vincent expertise expands to many areas of Quality Assurance, Regulatory Affairs and Validation, including; eBLA submission preparation, facility and equipment design review, process development and validation, project management, and utility and process equipment qualification. He has been involved in the various aspects of bringing many new drug manufacturing facilities on-line, from design concept and engineering, through construction and start-up, to the qualification/validation, and licensing phases. He has presented many training seminars and written many articles regarding validation topics. Mr. Vincent teaches "Validation Program for Pharmaceutical, Biotechnology and Medical Device Industries "RA 776" at San Diego State University (SDSU) for their Regulatory Affairs Master Degree program. Mr. Vincent has a degree in Industrial Microbiology and Mechanical Engineering Technology. He has been consulting for many companies nationally and internationally.

Dr. Vivienne Yankah, CQE
Manager, Process Improvement Sciences
Sanofi Pasteur

Dr. Vivienne Yankah is Manager, Process Improvement Sciences at sanofi-pasteur Limited, Toronto Canada. Her responsibilities include reviewing and approving cleaning validation protocols and reports, providing leadership to project/working groups on validation studies or investigations and developing documents for communicating the scope and strategy of process validation and process improvement. She holds a Ph.D degree with specialty in Biochemistry and Biotechnology of Lipids and was a Post-Doctoral research fellow in the US for four years. Dr. Yankah has eight years industry experience, is a Certified Quality Engineer with the American Society for Quality and has six sigma certification.

Program Content

Day 1 Thursday, August 14th, 2008
8:00 AM - 8:30 AM

Registration and Continental Breakfast

8:30 AM – 10:15 AM

Best Practices in Establishing Media Fill Requirements

  • Define the expectation of media fills in proving sterility assurance
  • Commonly observed regulatory deficiencies with current practices
  • Media fill requirements and acceptance criteria
  • Review industry’s concerns regarding media fills
  • Discuss conditions and practices to avoid

Management of Media Fills (Process Simulation Runs)

  • Review media fill frequency and size of runs
  • Discuss media fill durations versus actual production lot sizes
  • Discuss media fill manipulations
  • Proper incubation methods and issues
  • Failure investigations and corrective actions
  • Developing a compliant media fill SOP
10:15 AM - 10:30 AM

Mid-Morning Refreshment Break

10:30 AM - 12:00 PM

Designing a Cleaning Validation Process for Aseptic Manufacturing

Implementing Quality in Designing the Cleaning Process

  • Adherence to regulatory guidance for cGMP : 21CFR 210 & 211
  • Considerations for process capability, consistency, and reliability
  • Process parameters for robust process design
  • Personnel training for running /performing the cleaning procedure
  • Document control for the cleaning process
  • Demonstrating process qualification in accordance with the expectations of the cleaning procedure

How to Design the Cleaning Process in an Aseptic Environment

  • Distinguish between validation and verification
  • Developing the times/cycles for the cleaning process
  • Identifying "critical " areas of cleaning procedure and equipment
  • Choosing the cleaning method and agent
  • Choosing the test criteria for markers supporting cleaning validation
  • Considerations for validation of test methods used for cleaning validation samples

Executing the Cleaning Validation Process

  • Types of sampling
  • Choosing the sampling locations
  • Deriving the acceptance criteria
  • Critical background information

Maintaining the Cleaning Process

  • Investigating non-conformances, out of specification test results
  • Monitoring the cleaning validation process
  • Opportunities for application of continuous process improvement

Interactive Exercise – Case Study

12:00 PM – 1:00 PM

Luncheon

1:00 PM – 2:30 PM

Aseptic Packaging Process - Equipment Selection Tools

General Aseptic Flow & Processes for Primary Packaging

  • Learn the general flow for aseptic processes
  • Common equipment used for aseptic process
  • Differences between terminal sterilization and aseptic technique
  • Learn facility design practices for aseptic areas
  • PAT practices and future potential PAT

Formulation & Sterilization Equipment Selection

  • Equipment used in the formulation of aseptic products
  • Sterilization equipment used for preparing parts for aseptic use
  • Select and implement equipment used in formulation or sterilization
  • Learn how to avoid pitfalls in this area

Filling/Freeze Dry Operations

  • Equipment used in filling operations
  • Understand what should be qualified
  • Simplified qualification approaches
  • Learn how to avoid some pitfalls in filling equipment selection

Interactive Activity: Developing Documents

Using a case study from a clinical contract laboratory, attendees will develop selected documentation for requirements gathering and vendor selection. Attendees will then compare and contrast the documents they develop with each other.

2:30 PM - 2:45 PM

Mid-Afternoon Refreshment

2:45 PM - 4:15 PM

Sterility Testing Program - Sampling and Incubation

  • Purpose of sterility testing and current industry issues
  • Steps for establishing a sterility sampling program
  • Common causes for sterility failures; equipment, process and personnel
  • Compendia requirements for media and incubation conditions
  • Comparing and interpreting sterility test results with media fill results
  • Product disposition issues: how to assure quality with known manufacturing deviations

Strategies for Investigating Sterility Failures

  • Using Corrective and Preventative Action Plan (CAPA)
  • Roles and responsibilities and how to conduct laboratory and manufacturing OOS investigations
  • Importance of trending results
  • Common deficiencies associated with OOS investigations
4:15 PM – 4:30 PM

Questions and Answers

 

Day 2 Friday, August 15th, 2008
8:00 AM - 8:30 AM

Continental Breakfast

8:30 AM – 10:30 AM

Regulatory Guidelines and Expectations for Good Aseptic Practices

  • Review GMP Guidelines and expectations for Aseptic Processing
  • Review the major components of aseptic processing
  • Reference the FDA 2004 Guidance for Sterile Drugs produced by Aseptic Processing.
  • Review references from EU/PICs/TGA/ cGMP and Annex #1 for Sterile Products
  • Review recent 483 citations for aseptic processing

Overview of Sterilization Principles

  • Principles/concepts of Sterilization
  • Discuss common methods of sterilization
    • Terminal sterilization
    • Steam sterilization
    • Dry Heat and radiation
    • Chemical/EtO
  • Common problems in sterile filtration
  • Steps for establishing sterilization cycles
  • Alternative methods of aseptic processing
    • Isolator usage
    • Blow-fill-and seal
    • RABS—Restricted Access Barrier Systems


10:30 AM - 10:45 AM

Mid-Morning Refreshment Break

10:45 PM – 12:00 PM

Cleanroom Design, Operations, and Validation for Aseptic Processing

Cleanroom and Processing Fundamentals

  • Defining and attaining an aseptic state
  • People in an aseptic area
  • Aseptic techniques
  • Environmental particles, microorganisms, and pyrogen
    behaviors
  • General product requirements

Cleanroom Technology Standards

  • Applicable regulations and guidelines
  • Design criteria and maintenance programs
  • Environmental control, cleaning, and sanitization programs
  • General aspects of process analysis
  • Filter integrity, decontamination time, and contamination
    curves
  • Cleaning and sanitation methodology and validation

Cleanroom Monitoring

  • Operator qualification
  • Reasons to monitor cleanrooms
  • Microbial monitoring
12:00 PM - 1:00 PM

Luncheon

1:00 PM – 2:30 PM

Auditing of Aseptic Processes and Facilities

  • Review the procedures, training, and records required for establishing a compliant auditing program.
  • Applying a quality system-based approach to auditing
  • Discuss risk management issues and benefits
  • Review areas of importance when auditing of Quality Systems (laboratory, manufacturing, packaging/labeling, etc.)
  • Review personnel training and documentation requirements
  • Discuss effective audit techniques and common pitfalls
  • Review regulatory guidelines regarding vendor and internal auditing

Interactive Workshop Session:

Conducting a Media Fill Failure Investigation

Attendees review the data and propose actions for the investigation.
2:30 PM – 2:45 PM

Questions and Answers (Conclusion of Program)

Who Should Attend?

This two day workshop program is directed towards Directors, Managers, Supervisors, Analysts, and Associates in the Pharmaceutical, Biopharmaceutical, and allied industries with responsibilities in the following areas:

  • Quality Control
  • Quality Assurance
  • Sterility Assurance
  • Engineering
  • Critical Systems and Maintenance
  • Manufacturing
  • Production
  • Process Development
  • Microbial Testing
  • Contamination Control
  • Environmental Monitoring
  • Cleaning Validation
  • Regulatory Affairs
  • Training

Registration Information:

Registration Fee: $875.00 + GST

Online Registration Payment Information Course Location & Hotel Accommodations

Registration Fee Includes:
Presentation Materials, Luncheon, and Refreshments
Cancellation/Substitutions Policy:
CANCELLATION POLICY: Cancellation is accepted in writing (by mail, or fax) up to 4 weeks before the program start date, after which cancellations are not accepted and do not qualify for refund or credit. All Cancellations are subject to a $210.00 CAD (incl. GST)/person processing fee. Substitution of delegate/s with the member/s of the same organization is permitted at any time. IPA reserves the right to postpone an event, prior to which time all the registered attendees will be notified a minimum of 2 weeks in advance. IPA shall not be responsible for any air fare, hotel or transportation costs incurred by registrant/s.

Certificate of Attendance:

All participants will receive a certificate of attendance upon completion of the course
For registration or any further information, please contact us at:
Tel: (416) 410-7402
Fax: (416) 491-5810